Androgenic anabolic steroid, cocaine and amphetamine abuse and adverse cardiovascular effects

Anabolic-androgenic steroids (AAS), a synthetic derivate of testosterone, have become a popular drug among athletes and bodybuilders to enhance muscle mass and improve the athletic performance. Many pathological effects such as hepatic and endocrine dysfunction, behavioural changes and cardiovascula...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:International journal of endocrinology and metabolism 2013-10, Vol.11 (4), p.e8755
Hauptverfasser: Martinez-Quintana, Efren, Saiz-Udaeta, Beatriz, Marrero-Negrin, Natalia, Lopez-Mérida, Xavier, Rodriguez-Gonzalez, Fayna, Nieto-Lago, Vicente
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue 4
container_start_page e8755
container_title International journal of endocrinology and metabolism
container_volume 11
creator Martinez-Quintana, Efren
Saiz-Udaeta, Beatriz
Marrero-Negrin, Natalia
Lopez-Mérida, Xavier
Rodriguez-Gonzalez, Fayna
Nieto-Lago, Vicente
description Anabolic-androgenic steroids (AAS), a synthetic derivate of testosterone, have become a popular drug among athletes and bodybuilders to enhance muscle mass and improve the athletic performance. Many pathological effects such as hepatic and endocrine dysfunction, behavioural changes and cardiovascular complications have been reported. Within these ast ones, we find an increase in left ventricular muscle mass, concentric myocardial hypertrophy, left ventricular diastolic dysfunction, arterial hypertension, prothrombotic effects, changes in the concentration of cholesterol levels, particularly a reduction in HDL cholesterol concentration, myocardial infarctions in relation to endothelial dysfunction, vasospasms or thrombosis and sudden cardiac death. We report the case of a 32-year-old patient with a history of arterial hypertension, depressive syndrome and consumption of cocaine, amphetamines and AAS who developed severe left ventricular systolic dysfunction and myocardial hypertrophy with signs of heart failure and peripheral arterial embolism.
doi_str_mv 10.5812/ijem.8755
format Article
fullrecord <record><control><sourceid>pubmed_cross</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_3968994</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>24719633</sourcerecordid><originalsourceid>FETCH-LOGICAL-c342t-e9a69652d8733b3fe3fa455567715d4da6be3524d2c7fdae33025059b7c133263</originalsourceid><addsrcrecordid>eNpVkE9LAzEQxYMotlYPfgHpVXB1k9kkm4tQiv-g4EXBi4RsMttu2d2UZFvw27u1tehp3sybeQM_Qi5pestzyu6qJTa3ueT8iAypZCJRNMuPDxo-BuQsxmWacpFLcUoGLJNUCYAh-Zy0Lvg5tpUdm9YUvu5F7DD4yt2MrbemarF33Ng0qwV2pvnpi3XcT90GQ6-tCa7yGxPtujZhjGWJtovn5KQ0dcSLfR2R98eHt-lzMnt9eplOZomFjHUJKiOU4MzlEqCAEqE0GedcSEm5y5wRBQJnmWNWls4gQMp4ylUhLQVgAkbkfpe7WhcNOottF0ytV6FqTPjS3lT6v9NWCz33Gw1K5EplfcD1LsAGH2PA8nBLU71lrLeM9ZZxv3v199lh8xcqfAN6aHpk</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Androgenic anabolic steroid, cocaine and amphetamine abuse and adverse cardiovascular effects</title><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><source>PubMed Central Open Access</source><source>PubMed Central</source><creator>Martinez-Quintana, Efren ; Saiz-Udaeta, Beatriz ; Marrero-Negrin, Natalia ; Lopez-Mérida, Xavier ; Rodriguez-Gonzalez, Fayna ; Nieto-Lago, Vicente</creator><creatorcontrib>Martinez-Quintana, Efren ; Saiz-Udaeta, Beatriz ; Marrero-Negrin, Natalia ; Lopez-Mérida, Xavier ; Rodriguez-Gonzalez, Fayna ; Nieto-Lago, Vicente</creatorcontrib><description>Anabolic-androgenic steroids (AAS), a synthetic derivate of testosterone, have become a popular drug among athletes and bodybuilders to enhance muscle mass and improve the athletic performance. Many pathological effects such as hepatic and endocrine dysfunction, behavioural changes and cardiovascular complications have been reported. Within these ast ones, we find an increase in left ventricular muscle mass, concentric myocardial hypertrophy, left ventricular diastolic dysfunction, arterial hypertension, prothrombotic effects, changes in the concentration of cholesterol levels, particularly a reduction in HDL cholesterol concentration, myocardial infarctions in relation to endothelial dysfunction, vasospasms or thrombosis and sudden cardiac death. We report the case of a 32-year-old patient with a history of arterial hypertension, depressive syndrome and consumption of cocaine, amphetamines and AAS who developed severe left ventricular systolic dysfunction and myocardial hypertrophy with signs of heart failure and peripheral arterial embolism.</description><identifier>ISSN: 1726-913X</identifier><identifier>EISSN: 1726-9148</identifier><identifier>DOI: 10.5812/ijem.8755</identifier><identifier>PMID: 24719633</identifier><language>eng</language><publisher>Iran: Kowsar</publisher><subject>Case Report</subject><ispartof>International journal of endocrinology and metabolism, 2013-10, Vol.11 (4), p.e8755</ispartof><rights>Copyright © 2013, Research Institute For Endocrine Sciences and Iran Endocrine Society; Published by Kowsar. 2013</rights><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c342t-e9a69652d8733b3fe3fa455567715d4da6be3524d2c7fdae33025059b7c133263</citedby><cites>FETCH-LOGICAL-c342t-e9a69652d8733b3fe3fa455567715d4da6be3524d2c7fdae33025059b7c133263</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC3968994/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC3968994/$$EHTML$$P50$$Gpubmedcentral$$Hfree_for_read</linktohtml><link.rule.ids>230,314,725,778,782,883,27913,27914,53780,53782</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/24719633$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Martinez-Quintana, Efren</creatorcontrib><creatorcontrib>Saiz-Udaeta, Beatriz</creatorcontrib><creatorcontrib>Marrero-Negrin, Natalia</creatorcontrib><creatorcontrib>Lopez-Mérida, Xavier</creatorcontrib><creatorcontrib>Rodriguez-Gonzalez, Fayna</creatorcontrib><creatorcontrib>Nieto-Lago, Vicente</creatorcontrib><title>Androgenic anabolic steroid, cocaine and amphetamine abuse and adverse cardiovascular effects</title><title>International journal of endocrinology and metabolism</title><addtitle>Int J Endocrinol Metab</addtitle><description>Anabolic-androgenic steroids (AAS), a synthetic derivate of testosterone, have become a popular drug among athletes and bodybuilders to enhance muscle mass and improve the athletic performance. Many pathological effects such as hepatic and endocrine dysfunction, behavioural changes and cardiovascular complications have been reported. Within these ast ones, we find an increase in left ventricular muscle mass, concentric myocardial hypertrophy, left ventricular diastolic dysfunction, arterial hypertension, prothrombotic effects, changes in the concentration of cholesterol levels, particularly a reduction in HDL cholesterol concentration, myocardial infarctions in relation to endothelial dysfunction, vasospasms or thrombosis and sudden cardiac death. We report the case of a 32-year-old patient with a history of arterial hypertension, depressive syndrome and consumption of cocaine, amphetamines and AAS who developed severe left ventricular systolic dysfunction and myocardial hypertrophy with signs of heart failure and peripheral arterial embolism.</description><subject>Case Report</subject><issn>1726-913X</issn><issn>1726-9148</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2013</creationdate><recordtype>article</recordtype><recordid>eNpVkE9LAzEQxYMotlYPfgHpVXB1k9kkm4tQiv-g4EXBi4RsMttu2d2UZFvw27u1tehp3sybeQM_Qi5pestzyu6qJTa3ueT8iAypZCJRNMuPDxo-BuQsxmWacpFLcUoGLJNUCYAh-Zy0Lvg5tpUdm9YUvu5F7DD4yt2MrbemarF33Ng0qwV2pvnpi3XcT90GQ6-tCa7yGxPtujZhjGWJtovn5KQ0dcSLfR2R98eHt-lzMnt9eplOZomFjHUJKiOU4MzlEqCAEqE0GedcSEm5y5wRBQJnmWNWls4gQMp4ylUhLQVgAkbkfpe7WhcNOottF0ytV6FqTPjS3lT6v9NWCz33Gw1K5EplfcD1LsAGH2PA8nBLU71lrLeM9ZZxv3v199lh8xcqfAN6aHpk</recordid><startdate>20131001</startdate><enddate>20131001</enddate><creator>Martinez-Quintana, Efren</creator><creator>Saiz-Udaeta, Beatriz</creator><creator>Marrero-Negrin, Natalia</creator><creator>Lopez-Mérida, Xavier</creator><creator>Rodriguez-Gonzalez, Fayna</creator><creator>Nieto-Lago, Vicente</creator><general>Kowsar</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>5PM</scope></search><sort><creationdate>20131001</creationdate><title>Androgenic anabolic steroid, cocaine and amphetamine abuse and adverse cardiovascular effects</title><author>Martinez-Quintana, Efren ; Saiz-Udaeta, Beatriz ; Marrero-Negrin, Natalia ; Lopez-Mérida, Xavier ; Rodriguez-Gonzalez, Fayna ; Nieto-Lago, Vicente</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c342t-e9a69652d8733b3fe3fa455567715d4da6be3524d2c7fdae33025059b7c133263</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2013</creationdate><topic>Case Report</topic><toplevel>online_resources</toplevel><creatorcontrib>Martinez-Quintana, Efren</creatorcontrib><creatorcontrib>Saiz-Udaeta, Beatriz</creatorcontrib><creatorcontrib>Marrero-Negrin, Natalia</creatorcontrib><creatorcontrib>Lopez-Mérida, Xavier</creatorcontrib><creatorcontrib>Rodriguez-Gonzalez, Fayna</creatorcontrib><creatorcontrib>Nieto-Lago, Vicente</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>International journal of endocrinology and metabolism</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Martinez-Quintana, Efren</au><au>Saiz-Udaeta, Beatriz</au><au>Marrero-Negrin, Natalia</au><au>Lopez-Mérida, Xavier</au><au>Rodriguez-Gonzalez, Fayna</au><au>Nieto-Lago, Vicente</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Androgenic anabolic steroid, cocaine and amphetamine abuse and adverse cardiovascular effects</atitle><jtitle>International journal of endocrinology and metabolism</jtitle><addtitle>Int J Endocrinol Metab</addtitle><date>2013-10-01</date><risdate>2013</risdate><volume>11</volume><issue>4</issue><spage>e8755</spage><pages>e8755-</pages><issn>1726-913X</issn><eissn>1726-9148</eissn><abstract>Anabolic-androgenic steroids (AAS), a synthetic derivate of testosterone, have become a popular drug among athletes and bodybuilders to enhance muscle mass and improve the athletic performance. Many pathological effects such as hepatic and endocrine dysfunction, behavioural changes and cardiovascular complications have been reported. Within these ast ones, we find an increase in left ventricular muscle mass, concentric myocardial hypertrophy, left ventricular diastolic dysfunction, arterial hypertension, prothrombotic effects, changes in the concentration of cholesterol levels, particularly a reduction in HDL cholesterol concentration, myocardial infarctions in relation to endothelial dysfunction, vasospasms or thrombosis and sudden cardiac death. We report the case of a 32-year-old patient with a history of arterial hypertension, depressive syndrome and consumption of cocaine, amphetamines and AAS who developed severe left ventricular systolic dysfunction and myocardial hypertrophy with signs of heart failure and peripheral arterial embolism.</abstract><cop>Iran</cop><pub>Kowsar</pub><pmid>24719633</pmid><doi>10.5812/ijem.8755</doi><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1726-913X
ispartof International journal of endocrinology and metabolism, 2013-10, Vol.11 (4), p.e8755
issn 1726-913X
1726-9148
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_3968994
source Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals; PubMed Central Open Access; PubMed Central
subjects Case Report
title Androgenic anabolic steroid, cocaine and amphetamine abuse and adverse cardiovascular effects
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-15T10%3A03%3A51IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-pubmed_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Androgenic%20anabolic%20steroid,%20cocaine%20and%20amphetamine%20abuse%20and%20adverse%20cardiovascular%20effects&rft.jtitle=International%20journal%20of%20endocrinology%20and%20metabolism&rft.au=Martinez-Quintana,%20Efren&rft.date=2013-10-01&rft.volume=11&rft.issue=4&rft.spage=e8755&rft.pages=e8755-&rft.issn=1726-913X&rft.eissn=1726-9148&rft_id=info:doi/10.5812/ijem.8755&rft_dat=%3Cpubmed_cross%3E24719633%3C/pubmed_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/24719633&rfr_iscdi=true